Case Name (Date)

Petros et al. v. Rahal Biosciences, Inc.
24-cv-3182, S.D.N.Y.
(April 2024)


Product/Service

ARMRA Colostrum dietary supplements


Allegations

Falsely marketing products as “research-backed” to provide various health benefits – including “strengthen[ing] immunity,” “fortify[ing] gut health,” and “activat[ing] hair growth” – without adequate scientific evidence to support such claims

Failing to include mandated disclaimers with disease treatment claims, in violation of FDA regulations


Status

Voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.



The Latest

Filters

TINA.org Files FTC Complaint against Homeaglow

Press Release

TINA.org Files FTC Complaint against Homeaglow

MADISON, CONN. Sept. 9, 2025 – An investigation by consumer advocacy organization truthinadvertising.org (TINA.org) has found that Homeaglow is deceptively advertising $19 home cleanings in order to lure consumers into…


Show More